- Home
- BBAI vs OGN Comparison
BBAI vs OGN Comparison
Compare BBAI & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAI
- OGN
- Stock Information
- Founded
- BBAI 2020
- OGN 1923
- Country
- BBAI United States
- OGN United States
- Employees
- BBAI N/A
- OGN N/A
- Industry
- BBAI EDP Services
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- BBAI Technology
- OGN Health Care
- Exchange
- BBAI Nasdaq
- OGN Nasdaq
- Market Cap
- BBAI 2.9B
- OGN 2.7B
- IPO Year
- BBAI N/A
- OGN N/A
- Fundamental
- Price
- BBAI $6.64
- OGN $8.92
- Analyst Decision
- BBAI Strong Buy
- OGN Buy
- Analyst Count
- BBAI 3
- OGN 3
- Target Price
- BBAI $5.83
- OGN $17.33
- AVG Volume (30 Days)
- BBAI 125.2M
- OGN 3.4M
- Earning Date
- BBAI 11-10-2025
- OGN 10-30-2025
- Dividend Yield
- BBAI N/A
- OGN 0.90%
- EPS Growth
- BBAI N/A
- OGN N/A
- EPS
- BBAI N/A
- OGN 2.69
- Revenue
- BBAI $152,561,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- BBAI N/A
- OGN N/A
- Revenue Next Year
- BBAI $13.83
- OGN $0.79
- P/E Ratio
- BBAI N/A
- OGN $3.32
- Revenue Growth
- BBAI 3.46
- OGN N/A
- 52 Week Low
- BBAI $1.51
- OGN $8.01
- 52 Week High
- BBAI $10.36
- OGN $19.05
- Technical
- Relative Strength Index (RSI)
- BBAI 44.53
- OGN 28.58
- Support Level
- BBAI $7.10
- OGN $9.14
- Resistance Level
- BBAI $7.83
- OGN $9.72
- Average True Range (ATR)
- BBAI 0.83
- OGN 0.32
- MACD
- BBAI -0.17
- OGN -0.16
- Stochastic Oscillator
- BBAI 7.86
- OGN 1.25
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment. Company generate revenue by providing customers with Edge AI-powered decision intelligence solutions and services for data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics and predictive visualization. It generate revenue from providing both software and services to customers.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.